Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription Articles published in Am J Clin Oncol Retrieve available abstracts of 48 articles: HTML format

Single Articles

January 2021
1. PUNEKAR SR, Becker DJ
   The Segmentation of Neuroendocrine Neoplasms According to Histology.
   Am J Clin Oncol. 2021;44:43.
   PubMed    
   
   
   
2. ABDEL-RAHMAN O
   Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.
   Am J Clin Oncol. 2021;44:43.
   PubMed    
   
   
   December 2020
3. MARKS EI, Matera R, Olszewski AJ, Yakirevich E, et al
   Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing Regimens.
   Am J Clin Oncol. 2020 Dec 8. doi: 10.1097/COC.0000000000000785.
   PubMed     Abstract available
   
   
   
4. TENG HW
   In Reply: Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer.
   Am J Clin Oncol. 2020;43:905-906.
   PubMed    
   
   
   
5. KOSTEK O
   Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer.
   Am J Clin Oncol. 2020;43:905-906.
   PubMed    
   
   
   
6. SHULMAN K, Musallam S, Epelbaum R, Haim N, et al
   The Older Adults With Rectal Cancer-Does Age Matter?: A Single-center Experience.
   Am J Clin Oncol. 2020;43:861-864.
   PubMed     Abstract available
   
   
   
7. PUNEKAR SR, Kaakour D, Masri-Lavine L, Hajdu C, et al
   Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.
   Am J Clin Oncol. 2020;43:846-849.
   PubMed     Abstract available
   
   
   November 2020
8. GOKSU SY, Ozer M, Kazmi SMA, Aguilera TA, et al
   Racial Disparities in Time to Treatment Initiation and Outcomes for Early Stage Anal Squamous Cell Carcinoma.
   Am J Clin Oncol. 2020;43:762-769.
   PubMed     Abstract available
   
   
   October 2020
9. LEIKER AJ, Wang CJ, Sanford NN, Aguilera TA, et al
   Feasibility and Outcome of Routine Use of Concurrent Chemoradiation in HIV-positive Patients With Squamous Cell Anal Cancer.
   Am J Clin Oncol. 2020;43:701-708.
   PubMed     Abstract available
   
   
   
10. SANFORD NN, Dee EC, Ahn C, Kazmi SA, et al
    Recent Trends and Overall Survival of Young Versus Older Adults With Stage II to III Rectal Cancer Treated With and Without Surgery in the United States, 2010-2015.
    Am J Clin Oncol. 2020;43:694-700.
    PubMed     Abstract available
    
    
    September 2020
11. SANFORD NN, Folkert MR, Aguilera TA, Beg MS, et al
    Trends in Primary Surgical Resection and Chemotherapy for Metastatic Colorectal Cancer, 2000-2016.
    Am J Clin Oncol. 2020 Sep 23. doi: 10.1097/COC.0000000000000764.
    PubMed     Abstract available
    
    
    
12. BOEHMER U, Clark MA, Ozonoff A, Winter M, et al
    Survivors' Perceptions of Quality of Colorectal Cancer Care by Sexual Orientation.
    Am J Clin Oncol. 2020;43:660-666.
    PubMed     Abstract available
    
    
    June 2020
13. BOEHMER U, Clark MA, Ozonoff A, Winter M, et al
    Survivors' Perceptions of Quality of Colorectal Cancer Care by Sexual Orientation.
    Am J Clin Oncol. 2020 Jun 26. doi: 10.1097/COC.0000000000000732.
    PubMed     Abstract available
    
    
    May 2020
14. SANFORD NN, Aguilera TA, Beg MS, Sanjeevaiah A, et al
    Patterns of Care for Stage II-III Rectosigmoid Cancers in the United States, 2004-2015.
    Am J Clin Oncol. 2020;43:311-318.
    PubMed     Abstract available
    
    
    
15. FRAZER ML, Yang G, Felder S, McDonald J, et al
    Determining Optimal Follow-up for Patients With Anal Cancer Following Chemoradiation.
    Am J Clin Oncol. 2020;43:319-324.
    PubMed     Abstract available
    
    
    April 2020
16. SANFORD NN, Ahn C, Beg MS, Sanjeevaiah A, et al
    Stage-specific Conditional Survival Among Young (Age Below 50 y) Versus Older (Age 50 y and Above) Adults With Colorectal Cancer in the United States.
    Am J Clin Oncol. 2020 Apr 21. doi: 10.1097/COC.0000000000000698.
    PubMed     Abstract available
    
    
    
17. BOSMA NA, Tilley D, Batra A, Cheung WY, et al
    Characterizing Urban-Rural Differences in Colon Cancer Outcomes: A Population-based Analysis Based on Travel Distance to Cancer Center.
    Am J Clin Oncol. 2020 Apr 21. doi: 10.1097/COC.0000000000000703.
    PubMed     Abstract available
    
    
    March 2020
18. JIAO X, Hay JW, Sadeghi S, Barzi A, et al
    Outcomes and Utilization of Adjuvant Chemotherapy for Stage II Colon Cancer in the Oxaliplatin Period: A SEER-Medicare Analysis.
    Am J Clin Oncol. 2020 Mar 16. doi: 10.1097/COC.0000000000000684.
    PubMed     Abstract available
    
    
    February 2020
19. ADDO-TABIRI NO, Chudasama R, Vasudeva R, Leiva O, et al
    Black Patients Experience Highest Rates of Cancer-associated Venous Thromboembolism.
    Am J Clin Oncol. 2020;43:94-100.
    PubMed     Abstract available
    
    
    January 2020
20. ZHANG C, Yin S, Tan Y, Huang J, et al
    Patient Selection for Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer: A Systematic Review and Meta-Analysis.
    Am J Clin Oncol. 2020 Jan 13. doi: 10.1097/COC.0000000000000663.
    PubMed     Abstract available
    
    
    
21. APPELT AL, Andersen RF, Lindebjerg J, Jakobsen A, et al
    Prognostic Value of Serum NPY Hypermethylation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Secondary Analysis of a Randomized Trial.
    Am J Clin Oncol. 2020;43:9-13.
    PubMed     Abstract available
    
    
    December 2019
22. LEHRER S, Rheinstein PH
    Increased Risk of Acute Myelogenous Leukemia After Early Onset but Not Late-Onset Colorectal Cancer.
    Am J Clin Oncol. 2019 Dec 23. doi: 10.1097/COC.0000000000000658.
    PubMed     Abstract available
    
    
    
23. MAHAL AR, Johung KL, Mahal BA, Nguyen PL, et al
    An Update to Changing Patterns of Anal Carcinoma in the United States.
    Am J Clin Oncol. 2019;42:887-897.
    PubMed     Abstract available
    
    
    November 2019
24. PRICOLO VE, Steingrimsson J, McDuffie TJ, McHale JM, et al
    Tumor Deposits in Stage III Colon Cancer: Correlation With Other Histopathologic Variables, Prognostic Value, and Risk Stratification-Time to Consider "N2c".
    Am J Clin Oncol. 2019 Nov 19. doi: 10.1097/COC.0000000000000645.
    PubMed     Abstract available
    
    
    
25. TAI CC, Chen WS, Jiang JK, Yang SH, et al
    Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer.
    Am J Clin Oncol. 2019 Nov 5. doi: 10.1097/COC.0000000000000637.
    PubMed     Abstract available
    
    
    September 2019
26. KOUSTAS E, Sarantis P, Theoharis S, Saetta AA, et al
    Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer.
    Am J Clin Oncol. 2019 Sep 11. doi: 10.1097/COC.0000000000000592.
    PubMed     Abstract available
    
    
    August 2019
27. HUO J, Bian J, Xie Z, Hong YR, et al
    Patterns of Postdiagnosis Depression Among Late-Stage Cancer Patients: Do Racial/Ethnic and Sex Disparities Exist?
    Am J Clin Oncol. 2019;42:675-681.
    PubMed     Abstract available
    
    
    July 2019
28. PEABODY J, Rahim A, Wilcox B, McGehee C, et al
    Clinical Utility of a Blood-based Protein Assay on Diagnostic Colonoscopy Referrals for Elevated-risk Colorectal Cancer Patients in Primary Care.
    Am J Clin Oncol. 2019 Jul 19. doi: 10.1097/COC.0000000000000578.
    PubMed     Abstract available
    
    
    June 2019
29. KOENIG JL, Toesca DAS, Harris JP, Tsai CJ, et al
    Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon Cancer.
    Am J Clin Oncol. 2019 Jun 3. doi: 10.1097/COC.0000000000000554.
    PubMed     Abstract available
    
    
    
30. WEGNER RE, Abel S, Hasan S, White RJ, et al
    Trends in Radiation Dose and Technique For Anal Canal Squamous Cell Carcinoma.
    Am J Clin Oncol. 2019;42:519-526.
    PubMed     Abstract available
    
    
    April 2019
31. ALI ND, Donohue K, Zandieh S, Chen C, et al
    Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living >/=24 Months: A Single Institutional Study.
    Am J Clin Oncol. 2019 Apr 9. doi: 10.1097/COC.0000000000000535.
    PubMed     Abstract available
    
    
    March 2019
32. LLOYD S, Baraghoshi D, Tao R, Garrido-Laguna I, et al
    Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival.
    Am J Clin Oncol. 2019 Mar 5. doi: 10.1097/COC.0000000000000529.
    PubMed     Abstract available
    
    
    February 2019
33. AHMED S, Baig T, Iqbal N, Le D, et al
    Effects of Social and Contextual Factors Including Marital Status and Children on the Use of Palliative Chemotherapy in Metastatic Colorectal Cancer.
    Am J Clin Oncol. 2019 Feb 15. doi: 10.1097/COC.0000000000000530.
    PubMed     Abstract available
    
    
    July 2018
34. CUBILLO A, Alvarez-Gallego R, Munoz M, Pond G, et al
    Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer.
    Am J Clin Oncol. 2018 Jul 2. doi: 10.1097/COC.0000000000000474.
    PubMed     Abstract available
    
    
    May 2018
35. CHEN EY, Blanke CD, Haller DG, Benson AB, et al
    A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer.
    Am J Clin Oncol. 2018 May 18. doi: 10.1097/COC.0000000000000465.
    PubMed     Abstract available
    
    
    April 2018
36. BATES JE, Choi G, Usuki KY, Katz AW, et al
    Impact of Right-sided Primary Tumor Location Among Patients With Oligometastatic Colorectal Cancer Treated With Stereotactic Body Radiotherapy.
    Am J Clin Oncol. 2018 Apr 16. doi: 10.1097/COC.0000000000000445.
    PubMed     Abstract available
    
    
    March 2018
37. MCCLURE LA, Sussman DA, Hernandez MN, Tannenbaum SL, et al
    Factors Associated With Receipt of Radiation Therapy for Rectal Cancer.
    Am J Clin Oncol. 2018;41:227-229.
    PubMed     Abstract available
    
    
    February 2018
38. NGUYEN P, Wuthrick E, Chablani P, Robinson A, et al
    Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.
    Am J Clin Oncol. 2018;41:140-146.
    PubMed     Abstract available
    
    
    
39. DESHMUKH AA, Zhao H, Franzini L, Lairson DR, et al
    Total Lifetime and Cancer-related Costs for Elderly Patients Diagnosed With Anal Cancer in the United States.
    Am J Clin Oncol. 2018;41:121-127.
    PubMed     Abstract available
    
    
    January 2018
40. LAURENT M, Des Guetz G, Bastuji-Garin S, Culine S, et al
    Chronological Age and Risk of Chemotherapy Nonfeasibility: A Real-Life Cohort Study of 153 Stage II or III Colorectal Cancer Patients Given Adjuvant-modified FOLFOX6.
    Am J Clin Oncol. 2018;41:73-80.
    PubMed     Abstract available
    
    
    
41. SHANKARAN V, Ortendahl JD, Purdum AG, Bolinder B, et al
    Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States.
    Am J Clin Oncol. 2018;41:65-72.
    PubMed     Abstract available
    
    
    
42. QIU H, Katz AW, Chowdhry AK, Usuki KY, et al
    Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.
    Am J Clin Oncol. 2018;41:53-58.
    PubMed     Abstract available
    
    
    December 2017
43. CHABLANI P, Nguyen P, Pan X, Robinson A, et al
    Perineural Invasion Predicts for Distant Metastasis in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation and Surgery.
    Am J Clin Oncol. 2017;40:561-568.
    PubMed     Abstract available
    
    
    
44. VOONG KR, Rashid A, Crane CH, Minsky BD, et al
    Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
    Am J Clin Oncol. 2017;40:555-560.
    PubMed     Abstract available
    
    
    
45. OSTI MF, Nicosia L, Agolli L, Gentile G, et al
    Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy.
    Am J Clin Oncol. 2017;40:535-542.
    PubMed     Abstract available
    
    
    
46. AHN DH, Wu C, Wei L, Williams TM, et al
    The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy.
    Am J Clin Oncol. 2017;40:531-534.
    PubMed     Abstract available
    
    
    October 2017
47. YEOP OH S, Bae Kim Y, Wook Suh K
    Oncologic Outcome of ypT1-2N0 Rectal Cancer After Neoadjuvant Chemoradiotherapy Compared With pT1-2N0 Rectal Cancer.
    Am J Clin Oncol. 2017;40:512-516.
    PubMed     Abstract available
    
    
    
48. CHARLTON ME, Karlitz JJ, Schlichting JA, Chen VW, et al
    Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study.
    Am J Clin Oncol. 2017;40:498-506.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: